+35.6%
GSK vs ADVB
-97.5%
+133.1%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | ADVB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | +4.2% | -4.4% | -0.1% |
| 7D | +1.7% | -13.9% | +15.6% | +1.6% |
| 30D | +7.0% | -68.1% | +75.2% | +6.4% |
| 3M | -2.7% | -73.4% | +70.7% | -3.3% |
| 6M | +1.4% | -70.8% | +72.2% | +1.1% |
| YTD | +5.3% | -66.1% | +71.4% | +4.5% |
| 1Y | +10.6% | -77.5% | +88.1% | +10.8% |
| All | +35.6% | -97.5% | +133.1% | +47.8% |
Cumulative growth
Daily Returns
Daily percentage return beside ADVB.
Daily Out/Under-Performance
Portfolio return minus ADVB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ADVB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded ADVB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling